Jagannada K Sastry

Title: Jagannada K Sastry: Innovator in Viral Inactivation

Introduction

Jagannada K Sastry is a notable inventor based in Houston, Texas. He has made significant contributions to the field of virology, particularly in the development of therapeutic methods to combat viral infections. His work focuses on innovative approaches to protect human cells from viruses, especially HIV.

Latest Patents

Jagannada K Sastry holds a patent for "CD4 peptides for binding to viral envelope proteins." This invention discloses compositions and methods for viral binding and inactivation, aimed at protecting target human CD4.sup.+ cells from HIV infection. The patent identifies peptides that include short sequences from CD4, which are particularly effective at binding to gp120. This binding inhibits or reduces HIV infection of human CD4.sup.+ cells through steric hindrance or catalytic inactivation of gp120. The invention encompasses improved CD4-based peptide compositions and therapeutic formulations with viral binding and HIV-inhibitory activity.

Career Highlights

Sastry is affiliated with the University of Texas System, where he continues to advance research in virology and therapeutic applications. His work has garnered attention for its potential impact on public health, particularly in the fight against HIV.

Collaborations

Some of his notable coworkers include Victor A Dwyer, Iv, and Ralph B Arlinghaus. Their collaborative efforts contribute to the innovative research environment at the University of Texas System.

Conclusion

Jagannada K Sastry's contributions to the field of virology through his patented inventions highlight the importance of innovative approaches in combating viral infections. His work not only advances scientific knowledge but also holds promise for therapeutic applications in the future.